The Department of Defense has turned its Operation Warp Speed coronavirus effort to therapeutics, announcing a $375 million purchase agreement Wednesday to buy Eli Lilly’s as-yet unproven antibody treatment.
The joint announcement with the Department of Health and Human Services, its Operation Warp Speed partner, turns the multibillion-dollar effort launched by President Trump at the White House in May toward antibody treatments.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.